In the SURMOUNT trials, participants on tirzepatide achieved weight reductions of 2022% of their starting body weight, while semaglutide-treated patients in comparable studies achieved approximately 1517%
Dont double up on doses
Curr Opin Plant Biol 79:102540 Pinto S, Viegas J, Cristelo C, Pacheco C, Barros S, Buckley ST, Garousi J, Graslund T, Santos HA, Sarmento B (2024) Bioengineered nanomedicines targeting the intestinal Fc receptor achieve the improved glucoregulatory effect of semaglutide in a type 2 diabetic mice model
Taurine release in developing mouse hippocampus is modulated by glutathione and glutathione derivatives
Retrieved from Friedrichsen, M., Breitschaft, A., Tadayon, S., et al